Maximising Your Drug Development Potential
At MBPharmaco Consulting, we offer quantitative clinical pharmacology (QCP) support and expertise to pharmaceutical and biotech companies to accelerate drug development. Our experienced team offers customised solutions relating to strategic QCP development plans to leverage the benefits of model-informed drug development (MIDD) with quality internal and external clinical documentation and publication.
With a track record of four decades of early and late-phase drug development experience in major pharmaceutical companies, our team is well-positioned to help partners in drug R&D. We are accountable for the quality delivery of clinical pharmacology components for submissions and successful approvals of 10 primary New Drug Applications (NDA) in diverse therapeutic areas.
Contact us today to maximise your drug development potential with our quantitative clinical pharmacology support.
Tailored Solutions for Your Clinical Development Goals
At MBPharmaco Consulting, our mission is to support our clients in achieving their clinical development goals by focusing on the timely delivery of medicines to patients. We offer customised solutions based on our expertise in quantitative clinical pharmacology and model-informed drug development (MIDD).
Our team of experts works closely with our clients to develop strategic QCP plans that align with their unique needs and goals. We provide quality internal and external clinical documentation and publication to ensure regulatory compliance and successful submissions.
Publication References
The team has authored a number of publications in the fields of MIDD (Model-Informed Drug Development) and clinical pharmacology, exploring various topics related to drug development, pharmacokinetics, pharmacodynamics, and clinical trial design.
Contact us today to learn more.
